Home | Generic Animal Drug Alliance

Latest News

	July 2020 GADA and GADA-CVM Meetings To Be Conducted Virtually In the effort to keep all GADA members safe and health during COVID-19, while continuing to conduct the important business of the alliance, both the July 22, 2020 GADA Meeting and the July 23, 2020 CVM-GADA meetings will be conducted virtually.
	2021 GADA-CVM Meeting Schedule Announced Plans are confirmed to conduct three in-person meetings in 2021 with CVM and related organizations, as follows: Wednesday, February 24, 2021 (GADA Quarterly/OS&C) Thursday, February 25, 2021 (HFV-170/HFV-140) Wednesday, June 23, 2021 (GADA Mid-Year/USP or IPEC) Thursday, June 24, 2021 (HFV-170/HFV-140) Wednesday, October 27, 2021 (GADA Quarterly?) Thursday, October 28, 2021 (HFV-170/HFV-140) Plans are developing for additional GADA Member Meetings including a late 2021 Annual Member Meeting; details to be announced soon.
	February 7, 2020 In November 2019 the FDA's Center for Veterinary Medicine (CVM) issued draft guidance #256 on compounding veterinary drugs from bulk pharmaceutical ingredients. This guidance is intended to define when certain pharmacy compounding practices are acceptable, and when they cross the line into illegal pharmaceutical manufacturing. It is critical that the legitimate generic pharmaceutical industry communicate our support of this guidance to representatives for our member-presence states and committee members who represent our interests. GADA's Legislative Action Subgroup has worked with its legal counsel and the Legislative and Public Affairs representatives at the Animal Health Institute (AHI) to draft some documents that can help with our outreach activities both from a company directed standpoint and an industry association platform. In the effort to keep GADA members and other stakeholders informed, we provide three documents for the public's information. Link 1: 2020 AHI-GADA Compounding 1 Pager Link 2: 2020 AHI-GADA Compounding Backgrounder Link 3: 2020 AHI-GADA Responses to Claims
	July 18, 2019 Recent Study: Increasing Expenditure on Pet Healthcare Services Drives the Companion Animal Specialty Drugs Market Poor lifestyles and health issues for companion animals are some of the primary factors that are generating the demand for companion animal specialty drugs in the near future, according to a new report by Future Market Insights (FMI), entitled "Companion Animal Drug Market: Humanization of pets, market consolidation, and incremental innovation set to define the market landscape: Global Industry Analysis and Opportunity Assessment 2015-2025."
	June 7, 2018 Vet API Workshop at USP: Updated Agenda Available Programming for the USP Workshop, July 18-19 in Rockville, MD now includes confirmed presentations by experts from USP, FDA-CVM, and industry and Q&A Panels. The Workshop is a must-attend for API manufacturers, suppliers, and animal drug sponsors with regulatory responsibilities. In-person and virtual attendance by WebEx are available. Registration and hotel information may be found here.
	January 2, 2018 GADA to Co-Sponsor Vet API Workshop at USP Uninterrupted availability of veterinary APIs to the pharmaceutical industry is critical. As regulatory and Pharmacopeial standards evolve, issues may arise resulting in Import Alerts, supply chain interruptions and drug shortages. This workshop, July 18-19, 2018 at USP in Rockville, MD, is open to the public and is designed to help understand the issues that arise between Industry and regulatory bodies pertaining to APIs and VMPs to better facilitate processes and provide solutions. The workshop will bring Industry and regulators together in an interactive environment with presentations and panel discussions covering all aspects of Veterinary Active Pharmaceutical Ingredients. For more information, click here.
	October 26, 2016 GADA and CVM Present Antimicrobial Sales & Distribution Reporting Training GADA will host a virtual training session on Wednesday, November 2, provided by CVM and presented by Sue Dessai of HFV 212 - Division of Surveillance, to assist members in new reporting requirements for sales and distribution of antimicrobial animal drugs. Click here for more information.
	August 3, 2016 GADA Announces New Chair Bill Zollers, Vice President of Regulatory Affairs - North America for Norbrook, Inc. has been appointed Chair for the Generic Animal Drug Alliance. Bill will fulfill the unexpired term vacated by former Chair Jennifer Johansson who recently resigned following her departure from Putney, Inc. Bill, as Chair of GADA, will represent GADA as Co-Leader (with Doug Rupp, GADA Vice Chair) of the AGDUFA III Negotiations Team and will fulfill all of the duties of the Chair as described in the GADA bylaws. Bill formerly served as both Vice Chair, and as Secretary, for GADA and brings a wealth of knowledge and experience to the role.